CDR-813

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameCDR-813
Drug Alias NameCDR-813CDR813
ClassificationBiologics > T cell engagers
Mechanisms of ActionMelanoma antigen preferentially expressed in tumors modulators
TargetsMelanoma antigen preferentially expressed in tumors
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCDR-Life Inc
China Registration ClassN/A

Develop Information

Active CompaniesCDR-Life Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A